These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001 [TBL] [Abstract][Full Text] [Related]
5. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
7. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Parsons CG; Stöffler A; Danysz W Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591 [TBL] [Abstract][Full Text] [Related]
8. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta peptides and glutamatergic synaptic dysregulation. Parameshwaran K; Dhanasekaran M; Suppiramaniam V Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990 [TBL] [Abstract][Full Text] [Related]
11. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567 [TBL] [Abstract][Full Text] [Related]
12. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy. Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Masters CL; Beyreuther K Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295 [TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related]
15. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919 [TBL] [Abstract][Full Text] [Related]
16. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338 [TBL] [Abstract][Full Text] [Related]
18. [Neurotransmitter anomalies in Alzheimer's disease]. Berger B Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545 [TBL] [Abstract][Full Text] [Related]
19. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease? Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173 [TBL] [Abstract][Full Text] [Related]
20. ROCK, PAK, and Toll of synapses in Alzheimer's disease. Salminen A; Suuronen T; Kaarniranta K Biochem Biophys Res Commun; 2008 Jul; 371(4):587-90. PubMed ID: 18466762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]